Schedule 13G ownership disclosure
QUINCE THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 22053A107
Event date: 2024-10-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Genextra S.p.A.
Shares: 2,806,611 · Class: 6.49%
- Francesco Micheli
Shares: 2,806,611 · Class: 6.49%
- Matteo Bruno Renzulli
Shares: 2,806,611 · Class: 6.49%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-25-004984
- Form type
- SCHEDULE 13G/A
- Filer
- Genextra S.p.A.
- CIK
- CIK 1559515
- Filed
- Feb 18, 2025
- Reporting period
- Oct 18, 2024
- Description
- Schedule 13G beneficial ownership